Evotec Reports Results of the Annual General Meeting 2026
Summary
Evotec held its 2026 Annual General Meeting and shareholders approved all agenda items. The meeting resulted in the election of Dieter Weinand and Dr. Wolfgang Hofmann to the Supervisory Board. Dieter Weinand was then appointed Chairman, replacing Prof. Dr. Iris Löw-Friedrich. Shareholders also re-elected Dr. Duncan McHale and Wesley Wheeler, and Evotec continues to position itself as a life science company focused on AI-enabled drug discovery and development.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected